BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...

The FDA approved a dedicated syringe for the administration of Humulin R U-500 insulin, eliminating the need for dose conversions for patients who used U-100 or tuberculin syringes. The dedicated ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Humulin is human insulin used for ...

Insulet To Develop New Version Of The OmniPod Insulin Pump For Use With Humulin R U-500 Concentrated Insulin For People With Type 2 Diabetes Bedford, MA (Marketwired) - Insulet Corporation (NASDAQ: ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Humulin is human insulin used for ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. HUMULIN contains the active ingredient biosynthetic human insulin (rbe ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to biosynthetic ...

Eli Lilly announced that it has decided to stop producing Humulin 50/50 (insulin isophane suspension [NPH] 50% [human, recombinant], regular insulin 50% [human, recombinant]) due to the declining use ...

Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits out-of-pocket monthly costs for some consumers. The Indianapolis drugmaker ...

GREENSBORO, N.C. — The headline reads, “Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month”. It's a great headline for millions of people. There are two ...